473 related articles for article (PubMed ID: 27161062)
21. Comparison of diagnostic performance between two prostate imaging reporting and data system versions: A systematic review.
Li W; Xin C; Zhang L; Dong A; Xu H; Wu Y
Eur J Radiol; 2019 May; 114():111-119. PubMed ID: 31005160
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
23. Application of Prostate Imaging Reporting and Data System Version 2 (PI-RADS v2): Interobserver Agreement and Positive Predictive Value for Localization of Intermediate- and High-Grade Prostate Cancers on Multiparametric Magnetic Resonance Imaging.
Chen F; Cen S; Palmer S
Acad Radiol; 2017 Sep; 24(9):1101-1106. PubMed ID: 28546032
[TBL] [Abstract][Full Text] [Related]
24. [Implications of PI-RADS Version 1 and Updated Version 2 on the Scoring of Prostatic Lesions in Multiparametric MRI].
Haas M; Günzel K; Penzkofer T; Maxeiner A; Fischer T; Miller K; Hamm B; Asbach P; Cash H
Aktuelle Urol; 2016 Sep; 47(5):383-7. PubMed ID: 27680189
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.
Lin WC; Muglia VF; Silva GE; Chodraui Filho S; Reis RB; Westphalen AC
Br J Radiol; 2016 Jun; 89(1062):20151056. PubMed ID: 27007818
[TBL] [Abstract][Full Text] [Related]
26. Structured reporting in radiologic education - Potential of different PI-RADS versions in prostate MRI controlled by in-bore MR-guided biopsies.
Garmer M; Karpienski J; Groenemeyer DH; Wagener B; Kamper L; Haage P
Br J Radiol; 2022 Mar; 95(1131):20210458. PubMed ID: 34914538
[TBL] [Abstract][Full Text] [Related]
27. Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis.
Lee CH; Vellayappan B; Tan CH
Br J Radiol; 2022 Mar; 95(1131):20210509. PubMed ID: 34520694
[TBL] [Abstract][Full Text] [Related]
28. Impact of Clinical History on Maximum PI-RADS Version 2 Score: A Six-Reader 120-Case Sham History Retrospective Evaluation.
Shankar PR; Kaza RK; Al-Hawary MM; Masch WR; Curci NE; Mendiratta-Lala M; Sakala MD; Johnson TD; Davenport MS
Radiology; 2018 Jul; 288(1):158-163. PubMed ID: 29664338
[TBL] [Abstract][Full Text] [Related]
29. Comparison between
Liu Y; Dong Y; Liu J; Zhang X; Lin M; Xu B
Prostate; 2021 Dec; 81(16):1329-1336. PubMed ID: 34516670
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
Benndorf M; Hahn F; Krönig M; Jilg CA; Krauss T; Langer M; Dovi-Akué P
Eur J Radiol; 2017 Aug; 93():9-15. PubMed ID: 28668436
[TBL] [Abstract][Full Text] [Related]
31. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.
Taghipour M; Ziaei A; Alessandrino F; Hassanzadeh E; Harisinghani M; Vangel M; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2019 Apr; 44(4):1520-1527. PubMed ID: 30361870
[TBL] [Abstract][Full Text] [Related]
32. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
[TBL] [Abstract][Full Text] [Related]
33. Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.
Lin WC; Westphalen AC; Silva GE; Chodraui Filho S; Reis RB; Muglia VF
Abdom Radiol (NY); 2016 Nov; 41(11):2209-2217. PubMed ID: 27364781
[TBL] [Abstract][Full Text] [Related]
34. The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20 ng/mL.
Wang ZB; Wei CG; Zhang YY; Pan P; Dai GC; Tu J; Shen JK
Biomed Res Int; 2021; 2021():3995789. PubMed ID: 34671673
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.
Rastinehad AR; Waingankar N; Turkbey B; Yaskiv O; Sonstegard AM; Fakhoury M; Olsson CA; Siegel DN; Choyke PL; Ben-Levi E; Villani R
PLoS One; 2015; 10(11):e0143404. PubMed ID: 26605548
[TBL] [Abstract][Full Text] [Related]
36. Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions.
Polanec SH; Helbich TH; Bickel H; Wengert GJ; Pinker K; Spick C; Clauser P; Susani M; Shariat S; Baltzer PAT
Invest Radiol; 2018 Dec; 53(12):736-741. PubMed ID: 29985792
[TBL] [Abstract][Full Text] [Related]
37. How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1.
Linhares Moreira AS; De Visschere P; Van Praet C; Villeirs G
Acta Radiol; 2021 Jun; 62(6):839-847. PubMed ID: 32702998
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of multiparametric MR imaging with PI-RADS V2 assessment in detecting infiltration of the neurovascular bundles prior to prostatectomy.
Sauer M; Weinrich JM; Fraune C; Salomon G; Tennstedt P; Adam G; Beyersdorff D
Eur J Radiol; 2018 Jan; 98():187-192. PubMed ID: 29279161
[TBL] [Abstract][Full Text] [Related]
39. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.
Rosenkrantz AB; Lim RP; Haghighi M; Somberg MB; Babb JS; Taneja SS
AJR Am J Roentgenol; 2013 Oct; 201(4):W612-8. PubMed ID: 24059400
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
